Press
Colorado Boulevard: Michelle Huneven and Claire Lombardo Discussion on Craft and the Shaping of Family Sagas in Pasadena
Open Book presents acclaimed novelists Michelle Huneven and Claire Lombardo in a literary event that explores the art of storytelling and the intimate dynamics of family narratives.
Healio: Gene Therapy Shows Long-Term Visual Acuity Improvements in Retinitis Pigmentosa
In this Healio Video Perspective from the ARVO meeting, SriniVas R. Sadda, MD, FARVO, discusses a long-term study evaluating MCO-010 for the treatment of retinitis pigmentosa.
Ophthalmology Times: SriniVas Sadda, MD, on High-Res Oct of Atrophic and Precursor Lesions in AMD
Improved axial resolution allows clearer visualization of early atrophic changes, including iRORA vs cRORA differentiation, as shared at the Heidelberg 2025 International SPECTRALIS Symposium – And Beyond (ISS).
Pasadena Now: Pasadena Literary Alliance Hosts Acclaimed Novelists Michelle Huneven And Claire Lombardo In Evening Conversation
The Pasadena Literary Alliance will present an evening conversation featuring acclaimed novelists Michelle Huneven and Claire Lombardo on Tuesday, June 17 at the Doheny Eye Institute in Pasadena.
Vision Monday: Doheny Eye Institute Appoints Emma Lessieur-Contreras, MD, Ph.D., as Principal Investigator
Doheny Eye Institute, one of the nation’s leading vision research institutions for more than 75 years, announced it is adding to its panel of vision scientists with the appointment of Emma Lessieur-Contreras, MD, Ph.D., as principal investigator.
Pasadena Now: Doheny Eye Institute Welcomes Emma Lessieur-Contreras, MD, PhD, as Principal Investigator
Dr. Lessieur-Contreras will continue her groundbreaking research on understanding the early stages of diabetic retinopathy.
Doheny Eye Institute Welcomes Emma Lessieur-Contreras, MD, PhD, as Principal Investigator
Dr. Lessieur-Contreras will continue her groundbreaking research on understanding the early stages of diabetic retinopathy.
Ophthalmology Times: ARVO 2025: Retina Extracellular Vesicles in Diabetic Retinopathy
By: Emma Lessieur-Contreras, MD, PhD, Martin David Harp, Hattie Hayes At...
Ophthalmology Times: ARVO 2025: OPA1 Mutation’s Effect on Retinal Ganglion Cells’ Electrical Function
By: Steven Barnes, PhD, Martin David Harp, Hattie Hayes At ARVO 2025, in...
Ophthalmology Times: ARVO 2025: Adaptive Optics Imaging of AMD
By: Yuhua Zhang, PhD, Martin David Harp, Hattie Hayes At ARVO 2025, in...
Modern Retina: iRORA Phenotypes Identified Through Fundus Autofluorescence Imaging
By: Lynda Charters The results of an investigation into iRORA identified...
Optometry Times: iRORA Phenotypes Characterized Using Fundus Autofluorescence
By: Lynda Charters The results of an investigation into iRORA identified...
Ophthalmology Times: ARVO 2025: In Vivo Imaging of RPE Metabolic Function in AMD
By: Xiaolin Wang, MS, Martin David Harp, Hattie Hayes At ARVO 2025, in...
Ophthalmology Times: ARVO 2025: Lipid metabolism altered by CFH (Y402H) polymorphism and chronic oxidative stress in iPSC-derived RPE cells
By: Peng Shang, PhD, Martin David Harp, Hattie Hayes At ARVO 2025, in...
Ophthalmology Times: ARVO 2025: Association between autosomal dominant Alzheimer disease and optic nerve head drusen
By: Danielle Gauthier, Martin David Harp, Hattie Hayes At ARVO 2025, in...
Optometric Management: OD Notebook: Manufacturing Deviations Prompt Voluntary Recall of Ophthalmic Products
By: Optometric Management Due to cGMP manufacturing deviations identified...
Vision Monday: Doheny Eye Institute Announces Kaustabh Ghosh, Ph.D. as the Mary D. Allen Endowed Chair in Vision Research
By: Vision Monday Staff PASADENA, Calif. — Doheny Eye Institute, one of...
Optician: ARVO Conference Presents Innovation & Hoya Research
By: Emma Spencer The Association for Research in Vision and Ophthalmology...
Did You Miss our KNX-1070 Radio Spots?
Getting the word out about the incredible research done every day at Doheny Eye Institute is no small task. As part of our strategic focus on continually amplifying our marketing and communications, we’re proud to have recently wrapped a radio promotion that ran in May and June 2024. Have a listen below!